Doxycycline Suppresses Vasculogenic Mimicry in Human Pterygium Fibroblasts

References

• Di Girolamo N, Chui J, Coroneo MT, Wakefield D. Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res. 2004;23(2):195–228. doi:10.1016/j.preteyeres.2004.02.002.
   PubMed Web of Science ®Google Scholar
• Wanzeler ACV, Barbosa IAF, Duarte B, Borges D. Mechanisms and biomarker candidates in pterygium development. Arquivos Brasilros de Oftalmologia. 2020;83:262–270.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhu Z, Zhang WX. Preliminary study of vascular mimicry in pterygium. Zhonghua Yan Ke Za Zhi. 2007;43(10):872–875.
   PubMedGoogle Scholar
• Fernández-Cortés M, Delgado-Bellido D, Oliver FJ. Vasculogenic mimicry: become an endothelial cell “but not so much.” Front Oncol. 2019;9:803–808.
   PubMed Web of Science ®Google Scholar
• Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ. Vascular channel formation by human melanoma cells in vivo and in vitro:vasculogenic mimicry. Am J Pathol. 1999;155(3):739–752. doi:10.1016/S0002-9440(10)65173-5.
   PubMed Web of Science ®Google Scholar
• Manarang JC, Otteson DC, McDermott AM. Expression of antimicrobial peptides by uveal and cutaneous melanoma cells and investigation of their role in tumor cell migration and vasculogenic mimicry. Curr Eye Res. 2017;42(11):1474–1481. doi:10.1080/02713683.2017.1339806.
   PubMed Web of Science ®Google Scholar
• Henehan M, Montuno M, De Benedetto A. Doxycycline as an anti-inflammatory agent: updates in dermatology. J Eur Acad Dermatol. 2017;31:1–23.
   Web of Science ®Google Scholar
• Clemens DL, Duryee MJ, Hall JH, Thiele GM, Thiele M. Relevance of the antioxidant properties of methotrexate and doxycycline to their treatment of cardiovascular disease. Pharmacol Therapeut. 2019;205:1–22.
   Web of Science ®Google Scholar
• Piacentini M, Borghetti RL, Zancanaro De Figueiredo MA, Cherubini K, Gonçalves Salum F. Doxycycline: an option in the treatment of ulcerated oral lesions? J Clin Pharm Ther. 2019;44(6):838–843. doi:10.1111/jcpt.13022.
   PubMed Web of Science ®Google Scholar
• Shehwaro N, Langlois A, Gueutin V, Gauthier M, Casenave M, Izzedine H. La doxycycline ou comment faire du neuf avec du vieux? Therapies. 2014;69(2):129–141. doi:10.2515/therapie/2013069.
   PubMedGoogle Scholar
• Ali I, Alfarouk KO, Reshkin SJ, Ibrahim ME. Doxycycline as potential anti-cancer agent. Anticancer Agents Med Chem. 2017;17(12):1617–1623.
   PubMed Web of Science ®Google Scholar
• Mei Y, Yu G, Lihua K, Bai Q, Junfang Z. Meta-analysis of prevalence of pterygium among people aged over 40 in China. Chinese J Exp Ophthalmol. 2019;37:190–196.
   Google Scholar
• Meng J, Sun B, Zhao X, Zhang D, Zhao X, Gu Q, Dong XY, Zhao N, Liu PM, Liu YR. Doxycycline as an inhibitor of the epithelial-to-mesenchymal transition and vasculogenic mimicry in hepatocellular carcinoma. Mol Cancer Ther. 2014;13(12):3107–3122. doi:10.1158/1535-7163.MCT-13-1060.
   PubMed Web of Science ®Google Scholar
• Yi Q, Zou W. The wound healing effect of doxycycline after corneal alkali burn in rats. J Ophthalmol. 2019; 2019:1–10. doi:10.1155/2019/5168652.
   Web of Science ®Google Scholar
• Peng XN, Xiao H, Tang M, Zhan ZY, Yang Y, Sun LM, Luo XL, Zhang AY, Ding XY. Mechanism of fibrosis inhibition in laser induced choroidal neovascularization by doxycycline. Exp Eye Res. 2018;176:88–97. doi:10.1016/j.exer.2018.06.030.
   PubMed Web of Science ®Google Scholar
• Rúa O, Larráyoz IM, Barajas MT, Velilla S, Martínez A. Oral doxycycline reduces pterygium lesions; results from a double blind, randomized, placebo controlled clinical trial. PLOS One. 2012;7(12):e52696. doi:10.1371/journal.pone.0052696.
   PubMed Web of Science ®Google Scholar
• Larrayoz IM, Rúa Ó, Velilla S, Martínez A. Transcriptomic profiling explains racial disparities in pterygium patients treated with doxycycline. Invest Ophthalmol Vis Sci. 2014;55(11):7553–7561. doi:10.1167/iovs.14-14951.
   PubMed Web of Science ®Google Scholar
• Larrayoz IM, de Luis A, Rua O, Velilla S, Cabello J, Martinez A. Molecular effects of doxycycline treatment on pterygium as revealed by massive transcriptome sequencing. PLOS One. 2012;7(6):e39359. doi:10.1371/journal.pone.0039359.
   PubMed Web of Science ®Google Scholar
• Cox CA, Amaral J, Salloum R, Guedez L, Reid TW, Jaworski C, John-Aryankalayil M, Freedman KA, Campos MM, Martinez A, et al. Doxycycline's effect on ocular angiogenesis: an in vivo analysis. Ophthalmology. 2010;117(9):1782–1791. doi:10.1016/j.ophtha.2010.01.037.
   PubMed Web of Science ®Google Scholar
• Chu WK, Choi HL, Bhat AK, Jhanji V. Pterygium: new insights. Eye. 2020;34(6):1047–1050. doi:10.1038/s41433-020-0786-3.
   PubMed Web of Science ®Google Scholar
• Ip MH, Chui JJ, Tat L, Coroneo MT. Significance of Fuchs flecks in patients with pterygium/pinguecula: earliest indicator of ultraviolet light damage. Cornea. 2015;34(12):1560–1563. doi:10.1097/ICO.0000000000000621.
   PubMed Web of Science ®Google Scholar
• Luo Q, Wang J, Zhao W, Peng Z, Liu X, Li B, Zhang H, Shan B, Zhang CF, Duan CJ. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematlo Oncol. 2020;13:1–15.
   PubMed Web of Science ®Google Scholar
• Kapoor C, Vaidya S, Wadhwan V, Hitesh  , Kaur G, Pathak A. Seesaw of matrix metalloproteinases (MMPs). J Cancer Res Ther. 2016;12(1):28–36. doi:10.4103/0973-1482.157337.
   PubMed Web of Science ®Google Scholar
• Liang J, Xing H, Wu X, Zhang L, Zhao J. Role of ovarian tumor stem-like cells sorted from human epithelial ovarian cancer SKOV3 cells in vasculogenic mimicry formation. Nan Fang Yi Ke Da Xue Xue Bao. 2019;39(9):1065–1070.
   PubMedGoogle Scholar
• Meng J, Chen S, Lei Y-Y, Han J-X, Zhong W-L, Wang X-R, Liu Y-R, Gao W-F, Zhang Q, Tan Q, et al. Hsp90β promotes aggressive vasculogenic mimicry via epithelial–mesenchymal transition in hepatocellular carcinoma. Oncogene. 2019;38(2):228–243. doi:10.1038/s41388-018-0428-4.
   PubMed Web of Science ®Google Scholar
• Zhang JT, Sun W, Zhang WZ, Ge CY, Liu ZY, Zhao ZM, Lu XS, Fan YZ. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5gamma2 signaling pathway. BMC Cancer. 2014;14(1):193–209. doi:10.1186/1471-2407-14-193.
   PubMedGoogle Scholar
• Xu XY, Zong Y, Gao YX, Sun XR, Zhao H, Luo WJ, Jia SY. VEGF induce vasculogenic mimicry of choroidal melanoma through the PI3k signal pathway. Biomed Res Int. 2019;2019:1–13.
   Web of Science ®Google Scholar
• Lu XS, Sun W, Ge CY, Zhang WZ, Fan YZ. Contribution of the PI3K/MMPs/Ln-5gamma2 and EphA2/FAK/Paxillin signaling pathways to tumor growth and vasculogenic mimicry of gallbladder carcinomas. Int J Oncol. 2013;42(6):2103–2115. doi:10.3892/ijo.2013.1897.
   PubMed Web of Science ®Google Scholar
• Chen QW, Lin WF, Yin ZF, Zou Y, Liang SF, Ruan SM, Chen PF, Li S, Shu QJ, Cheng BB, et al. Melittin inhibits hypoxia-induced vasculogenic mimicry formation and epithelial-mesenchymal transition through suppression of HIF-1α/Akt pathway in liver cancer. Evid Based Complement Alternat Med. 2019;2019:1–10. doi:10.1155/2019/9602935.
   Web of Science ®Google Scholar